Key statistics
As of last trade N4 Pharma PLC (0GO:FRA) traded at 0.001, 0.00% below its 52-week high of 0.001, set on Feb 13, 2026.
52-week range
| Open | 0.001 |
|---|---|
| High | 0.001 |
| Low | 0.001 |
| Bid | 0.001 |
| Offer | 0.0255 |
| Previous close | 0.001 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 832.28m |
| Free float | 517.34m |
| P/E (TTM) | -- |
| Market cap | 3.95m GBP |
| EPS (TTM) | -0.0025 GBP |
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Announcements
- Business and Operational Update
- Interim Results
- Partnership with University of Strathclyde’s CMAC
- N4 Pharma’s Nuvec® Targets Lung Cancer Cells
- Notice of Results, Analyst & Investor Presentation
- Investor Event and Presentation
- Article on Nuvec®’s Potential in RNA Therapeutics
- Investor Webinar
- Directorate Change
- Result of AGM
More ▼
